UnitedHealth Group Incorporated (UNH) FY2024 Q1 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2024-01-01 to 2024-03-31

Swipe to see the full flow
UnitedHealth Group Incorporated cash flow reconciliation, Jan 1, 2024 through Mar 31, 2024One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Orange marks positive customer-advance and deferred-revenue changes that add to operating cash in the reconciliation. These are net changes, not gross customer receipts. Negative changes are neutral reconciliation adjustments; they do not by themselves identify cash payments. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Loss on sale of subsidiary → operating reconciliation: $7,086,000,000.00Medical costs payable → operating reconciliation: $2,069,000,000.00Depreciation and amortization → operating reconciliation: $997,000,000.00Share-based compensation → operating reconciliation: $372,000,000.00Other, net → operating reconciliation: $179,000,000.00Unearned revenues → operating reconciliation: $9,000,000.00operating reconciliation → Net cash from operating activities: $1,144,000,000.00operating reconciliation → Net (loss) earnings: $1,221,000,000.00operating reconciliation → Accounts receivable: $6,162,000,000.00operating reconciliation → Other assets: $1,927,000,000.00operating reconciliation → Accounts payable and other liabilities: $231,000,000.00operating reconciliation → Deferred income taxes: $27,000,000.00Proceeds from short-term borrowings, net → financing reconciliation: $6,189,000,000.00Proceeds from issuance of long-term debt → financing reconciliation: $5,925,000,000.00Customer funds administered → financing reconciliation: $1,745,000,000.00Proceeds from common stock issuances → financing reconciliation: $486,000,000.00financing reconciliation → Net cash from financing activities: $8,231,000,000.00financing reconciliation → Common share repurchases: $3,072,000,000.00financing reconciliation → Cash dividends paid: $1,729,000,000.00financing reconciliation → Repayments of long-term debt: $750,000,000.00financing reconciliation → Other, net: $563,000,000.00Net cash used in investing activities → investing reconciliation: $6,340,000,000.00Sales of investments → investing reconciliation: $2,976,000,000.00Maturities of investments → investing reconciliation: $2,314,000,000.00investing reconciliation → Purchases of investments: $4,798,000,000.00investing reconciliation → Other, net: $3,083,000,000.00investing reconciliation → Cash paid for acquisitions, net of cash assumed: $3,006,000,000.00investing reconciliation → Purchases of property, equipment and capitalized software: $743,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $25,427,000,000.00Net cash from operating activities → Cash sources and uses: $1,144,000,000.00Net cash from financing activities → Cash sources and uses: $8,231,000,000.00Cash sources and uses → Exchange-rate effect: $48,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $28,414,000,000.00Cash sources and uses → Net cash used in investing activities: $6,340,000,000.00Net (loss) earnings: -$1,221,000,000.00Net (loss) earnings−$1.22 BDepreciation and amortization: $997,000,000.00Depreciation & amortization+$997.00 MDeferred income taxes: -$27,000,000.00Deferred income taxes−$27.00 MShare-based compensation: $372,000,000.00Stock-based compensation+$372.00 MLoss on sale of subsidiary: $7,086,000,000.00Business sale gain & loss+$7.09 BOther, net: $179,000,000.00Other non-cash items+$179.00 MAccounts receivable: -$6,162,000,000.00Accounts receivable−$6.16 BOther assets: -$1,927,000,000.00Other operating assets−$1.93 BMedical costs payable: $2,069,000,000.00Health insurance liabilities+$2.07 BAccounts payable and other liabilities: -$231,000,000.00Payables & accrued liabilities−$231.00 MUnearned revenues: $9,000,000.00Unearned revenue+$9.00 MNet cash from operating activities: $1,144,000,000.00Operating cash+$1.14 Boperating reconciliation: $10,712,000,000.00Common share repurchases: -$3,072,000,000.00Common stock repurchases−$3.07 BCash dividends paid: -$1,729,000,000.00Common dividends paid−$1.73 BProceeds from common stock issuances: $486,000,000.00Common stock issued+$486.00 MRepayments of long-term debt: -$750,000,000.00Long-term debt repaid−$750.00 MProceeds from short-term borrowings, net: $6,189,000,000.00Commercial paper, net+$6.19 BProceeds from issuance of long-term debt: $5,925,000,000.00Long-term debt issued+$5.93 BCustomer funds administered: $1,745,000,000.00Deposits, net+$1.75 BOther, net: -$563,000,000.00Other financing, net−$563.00 MNet cash from financing activities: $8,231,000,000.00Financing cash+$8.23 Bfinancing reconciliation: $14,345,000,000.00Purchases of investments: -$4,798,000,000.00Investment purchases−$4.80 BSales of investments: $2,976,000,000.00AFS securities sales+$2.98 BMaturities of investments: $2,314,000,000.00AFS securities maturities+$2.31 BCash paid for acquisitions, net of cash assumed: -$3,006,000,000.00Acquisitions, net of cash−$3.01 BPurchases of property, equipment and capitalized software: -$743,000,000.00PP&E purchases−$743.00 MOther, net: -$3,083,000,000.00Other investing, net−$3.08 BNet cash used in investing activities: -$6,340,000,000.00. Cash required to fund net payments.Investing cash−$6.34 Binvesting reconciliation: $11,630,000,000.00Cash sources and uses: $34,802,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $25,427,000,000.00Beginning cash$25.43 BEnding cash: Cash, cash equivalents, and restricted cash: $28,414,000,000.00Ending cash$28.41 BExchange-rate effect: -$48,000,000.00FX effect−$48.00 MCASH RECONCILIATIONOperatingflowsFinancingflowsInvestingflowsNet loss −$1.22B + net operating adjustments $2.37B = operating cash +$1.14BFree cash flow$401.00 MOperating cash − cash spent on PP&ECash flow / Net incomeNot meaningfulOperating cash flow ÷ net incomeNet cash change+$2.99 BEnding cash − beginning cash
Chart details

UnitedHealth Group Incorporated cash flow reconciliation, Jan 1, 2024 through Mar 31, 2024

Cash flows for Jan 1, 2024 through Mar 31, 2024. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2023. Ending cash: Mar 31, 2024. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2023
25,427,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
1,144,000,000 US dollars. Net cash provided.
Net (loss) earnings
negative 1,221,000,000 US dollars
Depreciation and amortization
997,000,000 US dollars
Deferred income taxes
negative 27,000,000 US dollars
Share-based compensation
372,000,000 US dollars
Loss on sale of subsidiary
7,086,000,000 US dollars
Other, net
179,000,000 US dollars
Accounts receivable
negative 6,162,000,000 US dollars
Other assets
negative 1,927,000,000 US dollars
Medical costs payable
2,069,000,000 US dollars
Accounts payable and other liabilities
negative 231,000,000 US dollars
Unearned revenues
9,000,000 US dollars
Investing activities
negative 6,340,000,000 US dollars. Net cash used.
Purchases of investments
negative 4,798,000,000 US dollars
Sales of investments
2,976,000,000 US dollars
Maturities of investments
2,314,000,000 US dollars
Cash paid for acquisitions, net of cash assumed
negative 3,006,000,000 US dollars
Purchases of property, equipment and capitalized software
negative 743,000,000 US dollars
Other, net
negative 3,083,000,000 US dollars
Financing activities
8,231,000,000 US dollars. Net cash provided.
Common share repurchases
negative 3,072,000,000 US dollars
Cash dividends paid
negative 1,729,000,000 US dollars
Proceeds from common stock issuances
486,000,000 US dollars
Repayments of long-term debt
negative 750,000,000 US dollars
Proceeds from short-term borrowings, net
6,189,000,000 US dollars
Proceeds from issuance of long-term debt
5,925,000,000 US dollars
Customer funds administered
1,745,000,000 US dollars
Other, net
negative 563,000,000 US dollars
Operating adjustment reconciliation
10,712,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
14,345,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
11,630,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 48,000,000 US dollars
Ending cash on Mar 31, 2024
28,414,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
34,802,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
2,987,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
Operating cash flow
1,144,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
743,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
401,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net loss −$1.22B + net operating adjustments $2.37B = operating cash +$1.14B. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 1,144,000,000 US dollars minus 743,000,000 US dollars equals 401,000,000 US dollars.
UnitedHealth Group Incorporated (UNH) FY2024 Q1 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!